AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 81 min read$VRSK

LISS SAMUEL G sold $851K of VRSK

LISS SAMUEL G sold 4,671 shares of Verisk Analytics, Inc. (VRSK) at $182.21 ($0.85M total) on 2026-06-05.

Original reporting
SEC EDGAR · LISS SAMUEL G
Published Jun 8, 2026, 8:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$VRSK
Neutral
medium confidence
Mentioned
$VRSK
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VRSKNeutralLow
01

Why it matters

The newest fact is the director’s open-market sale size, price, and that it was not under a pre-arranged 10b5-1 plan, which can influence sentiment but lacks fundamental context.

02

Market read

Traders may monitor for additional insider transactions or confirm whether this sale is part of a broader pattern; otherwise impact is likely modest.

03

What to watch

The filing doesn’t state tax, diversification, or personal liquidity needs; traders should compare with prior insider patterns and total insider net activity.

Relevance 5/10Novelty 8/10Timing: filed 2026-06-08 (sale dated 2026-06-05)

Background

The article is an SEC Form 4 insider transaction disclosure for Verisk Analytics, Inc.

Company-level read

Ticker impact

$VRSKNeutralMedium confidence
Context

Verisk director Liss Samuel G filed an open-market sale of 4,671 shares at $182.21 on 2026-06-05 (no 10b5-1 plan).

Expected impact

Likely limited, short-lived sentiment effect; watch for follow-on insider activity or unusual volume rather than expecting a sustained move.

Evidence & confidence

This is a primary SEC Form 4 disclosure, but the transaction is a single director sale and the article provides no accompanying operational/regulatory catalyst.

Market effects

Sector

Minimal; this is company-specific insider activity with no stated sector-wide signal.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Director sales can be routine liquidity management; absence of a 10b5-1 plan doesn’t necessarily imply negative information.

Key entities

  • issuer
    Verisk Analytics, Inc.

    Subject of the SEC Form 4 insider transaction disclosure.

  • insider
    Liss Samuel G

    Director who sold 4,671 shares of VRSK on 2026-06-05.

Read at source← All news

Related articles

AUG 8
$VRSKMedAI 8/10

Verisk Analytics (VRSK) Q2 2026 Earnings Call Transcript

Verisk Analytics (NASDAQ:VRSK) reported Q2 2026 revenue of $806 million, up 4.3% reported and 5.8% organic constant currency. Adjusted EBITDA was $464 million, up 7.4% on the same basis. Subscription revenue was 83% of total, and diluted adjusted EPS was $1.98. Full-year guidance was reaffirmed: revenue $3.19B to $3.24B and EPS $7.45 to $7.75.

aol.com6 min
AUG 7
$VRSKMedAI 8/10

Verisk Ordered to Move Ahead With $2.35 Billion AccuLynx Merger

A Delaware Chancery Court judge ordered Verisk Analytics to proceed with its $2.35 billion merger with AccuLynx, rejecting AccuLynx’s bid to raise the deal price over antitrust clearance concerns. The judge cited willful conduct by AccuLynx for a failed closing condition and awarded AccuLynx damages for direct costs plus interest. The deal still requires HSR Act clearance and FTC approval.

news.bloomberglaw.com4 min
JUL 29
$VRSKMedAI 8/10

[VRSK Q2 2026 Earnings Call] Verisk Q2 Organic Revenue Hits 5.8% as XactAI Users Jump 10x to 7,000, but Transactional Drag Persists — BigGo Finance

Verisk Analytics (VRSK) reported Q2 2026 revenue of $806 million, up 5.8% organic constant currency, driven by 8% subscription growth (83% of revenue). Transactional revenue fell 4.2% due to softer commercial property quotes and weaker weather demand. XactAI users rose 10x to 7,000. Full-year guidance of $3.19–$3.24B revenue and $1.79–$1.83B adj. EBITDA was reaffirmed.

finance.biggo.com7 min
JUL 29
$VRSKMed

Verisk Vaults on Releasing Q2 Results

Verisk (NASDAQ: VRSK) reported Q2 results for the quarter ended June 30, 2026. Net income fell 9.8% to $229 million, citing higher tax rate, net interest expense, and legal fees tied to litigation. The company paid a $0.50 dividend per share and launched a $200 million accelerated share repurchase, with an initial delivery of 949,190 shares at $179.10. Shares rose 9.6% to $221.87.

baystreet.ca3 min